National Asthma Education and Prevention Program Working Group Report on the Cost Effectiveness of Asthma Care

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 3 II SUPPL., 1996, Pages

  Sullivan, Sean ^a   Elixhauser, Anne ^a   Buist, A Sonia ^a   Luce, Bryan R ^a   Eisenberg, John ^a   Weiss, Kevin B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; ASTHMA; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH PROGRAM; LUNG FUNCTION; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0029839195     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm/154.3_pt_2.s84     Document Type: Article

References (20)

1. Grimes, D. A. 1993. Technology follies: the uncritical acceptance of medical innovation. J.A.M.A. 269:3030-3033.
2. Banta, H. D., and B. R. Luce. 1993. Health Care Technology and Its Assessment. Oxford University Press, New York.
3. National Heart, Lung, and Blood Institute. 1991. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. U.S. Department of Health and Human Services, Bethesda, MD. NIH Publication No. 91-3042.
4. U.S. Office of Technology Assessment. 1978. Assessing the Efficacy and Safety of Medical Technologies. U.S. Government Printing Office, Washington, DC.
5. Institute of Medicine, Division of Health Sciences Policy. 1985. Assessing Medical Technologies. National Academy Press, Washington, DC.
6. Eisenberg, J. M., K. A. Schulman, H. Glick, and H. Koffer. 1994. Pharmocoeconomics: economic evaluation of pharmaceuticals. In B. L. Strom, editor. Pharmacoepidemiology, 2nd ed. J. Wiley, New York.
7. Warner, K. E., and B. R. Luce. 1982. Cost-Benefit and Cost-Effectiveness Analysis in Health Care: Principles, Practice, and Potential. Health Administration Press, Ann Arbor, MI.
8. Weinstein, M. C., and W. B. Stason. 1977. Foundations of cost-effectiveness analysis for health and medical practices. N. Engl. J. Med. 296:716-721.
9. National Heart, Lung, and Blood Institute. 1994. Supplement: asthma outcome measures. Am. J. Respir. Crit. Care Med. 149(2):S1-S90.
10. Schulpher, M. J., and M. J. Buxton. 1993. The episode-free day as a composite measure of effectiveness. PharmacoEconomics 4:345-352.
11. Rothman, M. L., and D. A. Revicki. 1993. Issues in the measurement of health status in asthma research. Med. Care 31(Suppl. 3):MS82-MS96.
12. Rice, D. P. 1966. Estimating the Cost of Illness. Health Economics Series No. 6. U.S. Government Printing Office, Washington, DC. DHEW Publication No. 947-6.
13. Hodgson, T. A., and M. R. Meiners. 1982. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem. Fund Q. Health Soc. 60:429-462.
14. National Heart, Lung, and Blood Institute. 1994. Chapter 8. Socioeconomics. In Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report. U.S. Department of Health and Human Services, Bethesda, Maryland. NIH Publication No. 94-3276.
15. Report on the cost of asthma in Australia. 1992. National Asthma Campaign.
16. Mellis, C. M., J. K. Peak, A. E. Bauman, A. J. Woolcock. 1991. The cost of asthma in New South Wales. Med. J. Aust. 155:522-528.
17. Glaxo Canada. 1993. The Costs of Adult Asthma in Canada. Communications Media for Education. Princeton, N.I.
18. Thompson, S. 1984. On the social cost of asthma. Eur. J. Respir. Dis. Suppl. 136:185-191.
19. Clark, T.J.H. 1990. The Occurrence and Cost of Asthma. Cambridge Medical Publications, West Sussex, UK.
20. Weiss, K. B., P. J. Gergen, and T. A. Hodgson. 1992. An economic evaluation of asthma in the United States. N. Engl. J. Med. 326:862-866.